====== 1926 ======
[[1925]]-[[1927]]
----
Charles Foix and Théophile Alajouanine first described the [[Foix-Alajouanine Syndrome]] in 2 young men (aged 29 y and 27 y), in [[1926]]
((Foix C, Alajouanine T. La myélite nécrotique subaigue. Rev Neurol (Paris) 1926;2:1–42.)).
----


The first case was reported in [[1837]] by Magnus. The syndrome was described by Foix Chavany et Marie in [[1926]]
((Foix C, Chavany JA, Marie J (1926) Diplégie facio-linguomasticatrice
d’origine souscorticale sans paralysie des membres
(contribution à l’étude de la localisation des centres de la face du
membre supérieur). Rev Neurol 33:214–219))
, and called SFMC by Weller (1993). His literature review of 62 SFMC allowed the differentiation of five clinical types: the classical and most common form associated with cerebrovascular disease, a subacute form caused by central nervous system infections, a developmental form, a reversible form in children with epilepsy and a rare type associated with neurodegenerative disorders
((Laurent-Vannier A, Fadda G, Laigle P, Dusser A, Leroy-Malherbe V.
[Foix-Chavany-Marie syndrome in a child caused by a head trauma]. Rev Neurol
(Paris). 1999 May;155(5):387-90. Review. French. PubMed PMID: 10427603.
)).
----
[[Brainstem tumor]]s were first described by Kummel in [[1881]]
((Kummel B. Beitrag Zur Kasuistik Der Gliom Des Pons Und Der Medulla Oblongata. Klin Medizin. (1881).))
and Monakow 
((Monakow C. Histoire naturelle des tumeurs cérébrales, en particulier du gliome. Encéphale. (1926):117–89.)).
The first nosological classification was reported in [[1926]] by Bailey and Cushing who emphasized, for the first time, that [[brainstem glioma]]s could develop from certain embryological cells 
((Bailey P, Cushing H. A classification of tumors of the glioma group on a hystogenesis basis. Philadelphia: Lippincot; (1926).)).